A new paraplegin mutation in a patient with primary progressive multiple sclerosis

Angelo Bellinvia, Luisa Pastò, Claudia Niccolai, Alessandra Tessa, Riccardo Carrai, Cristiana Martinelli, Marco Moretti, Maria Pia Amato, Filippo Maria Santorelli, Sandro Sorbi, Sabrina Matà

Research output: Contribution to journalArticlepeer-review


Primary progressive multiple sclerosis (PPMS) presents with clinical signs of slowly progressive long tract dysfunction that can overlap with neurodegenerative disorders, such as hereditary spastic paraplegia (HSP). Herein, we present two siblings in whom we have identified a novel mutation in the paraplegin (SPG7) gene. The proband, a 49-year-old woman, presented with a five-year history of progressive spastic paraparesis and ataxia. Brain MRI showed mild cerebellar atrophy. The genetic study revealed a homozygous mutation in the SPG7 gene, that led to the diagnosis of HSP. Four years previously, the younger brother had complained of slowly progressive spastic-ataxic gait, that started one year before; MRI had disclosed multiple areas of white matter hyperintensity with contrast enhancement. A diagnosis of active PPMS was made, and the patient started Disease-Modifying Therapy with further clinical and radiological stability. Once a genetic diagnosis was achieved in his sister, the patient underwent SPG7 testing, which disclosed the same mutation. Whether MS is a mimicry of HSP or it represents "double trouble" condition in this patient, it remains undetermined.

Original languageEnglish
Article number102302
JournalMultiple Sclerosis and Related Disorders
Publication statusPublished - Sep 2020


  • Hereditary spastic paraparesis
  • Multiple sclerosis
  • SPG7
  • White matter changes

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology


Dive into the research topics of 'A new paraplegin mutation in a patient with primary progressive multiple sclerosis'. Together they form a unique fingerprint.

Cite this